Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of anakinra for secondary injury after spontaneous supratentorial intracerebral haemorrhage
NL-OMON60725Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of anakinra in intracerebral hemorrhage (ICH) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Oedema extension distance. Started Oct 2024; status: recruiting.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON60725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60725.